InvestorsHub Logo
Followers 8
Posts 394
Boards Moderated 0
Alias Born 07/22/2011

Re: None

Friday, 07/19/2019 3:48:52 PM

Friday, July 19, 2019 3:48:52 PM

Post# of 34625
Let me see if I have this straight. Through an unexpectedly early press release, we learn that Marker, in an admittedly small sample size, may have some of the best results ever in treating pancreatic cancer, one of the hardest cancers to treat, with a drug that is not even optimized for that particular cancer. And the market rewards us with a 28% drop in share price? I would rather cut off one of my fingers than sell shares down here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News